Nagoya
Japan
Nagoya University - Department of Neurology
Chronic inflammatory demyelinating polyneuropathy (CIDP), rituximab, autoimmune nodopathies, immunoglobulin G4 (IgG4) autoantibodies, neurofascin-155 (NF155), clinical trial
TDP-43, ALS, early-phase insulin secretion, Cav1.2 calcium channel, exocytosis
Multiple system atrophy, COQ2, ubiquinol, clinical trial, disease-modifying therapy
sporadic amyotrophic lateral sclerosis, AMPA receptor, perampanel, ALSFRS-R, ADAR2
Parkinson's disease, autonomic function, orthostatic hypotension, heart rate variability, pulse rate variability, wearable sensors